Works matching AU Yeung-Chul Mun

Results: 81
    1
    2
    3
    4
    5

    Changes in Osteoblastic Activity in Patient Who Received Bortezomib as Second Line Treatment for Plasma Cell Myeloma: A Prospective Multicenter Study.

    Published in:
    BioMed Research International, 2014, v. 2014, p. 1, doi. 10.1155/2014/245247
    By:
    • Ki-Seong Eom;
    • Seok Jin Kim;
    • Je-Jung Lee;
    • Cheolwon Suh;
    • Jin Seok Kim;
    • Sung-Soo Yoon;
    • Byung Soo Kim;
    • Hye Jin Kang;
    • Young Jin Choi;
    • Chul Soo Kim;
    • Yang Soo Kim;
    • Jae-Yong Kwak;
    • Yoo Jin Kim;
    • Young Don Joo;
    • Yeung-Chul Mun;
    • Deog Yeon Jo;
    • Joon Seong Park;
    • Chi-Young Park;
    • Sung-Hyun Kim;
    • Chang-Ki Min
    Publication type:
    Article
    6
    7
    8
    9
    10
    11
    12
    13

    Cytogenetic and Molecular Failure at 12 Months will be the Optimal Time Point for BCR-ABL1 Tyrosine Kinase Domain Mutation Analysis in Patients with Chronic Myeloid Leukemia: The Analysis Based on 2013 European LeukemiaNet Recommendation.

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2017, v. 17, p. S17, doi. 10.1016/j.clml.2017.09.045
    By:
    • Hee-Je Kim;
    • Hea-Lyun Yoo;
    • Won-Sik Lee;
    • Hyeong-Joon Kim;
    • Jee Hyun Kong;
    • Yunsuk Choi;
    • Young Rok Do;
    • Jae-Yong Kwak;
    • Sukjoong Oh;
    • Sung Hyun Kim;
    • Jeong-A. Kim;
    • Dae Young Zang;
    • Yeung-Chul Mun;
    • Young-Woong Won;
    • Sung-Eun Lee;
    • Dong-Wook Kim
    Publication type:
    Article
    14
    15

    Bortezomib-Melphalan-Prednisone (VMP) Versus MP as Initial Treatment for Very Elderly Patients With Newly Diagnosed Multiple Myeloma.

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2017, v. 17, p. e70, doi. 10.1016/j.clml.2017.03.126
    By:
    • Kim, Min Kyoung;
    • Kim, Kihyun;
    • Yoon, Do Hyun;
    • Suh, Cheolwon;
    • Moon, Joon Ho;
    • Lee, Yoo Jin;
    • Lee, Jae Hoon;
    • Jung, Sung-Hoon;
    • Lee, Je-Jung;
    • Kim, Hyo Jung;
    • Bae, Sung Hwa;
    • Kim, Jin Seok;
    • Lee, Jeong-Ok;
    • Eom, Hyeon Seok;
    • Lee, Won-Sik;
    • Kang, Hye Jin;
    • Mun, Yeung-Chul;
    • Do, Young Rok;
    • Hyun, Myung Soo
    Publication type:
    Article
    16

    Phase 2 Study Using Intravenous Busulfan and Melphalan Conditioning Regimen for Autologous Stem Cell Transplantation in Patients with Multiple Myeloma; Final Analysis (KMM150).

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2017, v. 17, p. e73, doi. 10.1016/j.clml.2017.03.133
    By:
    • Lee, Je-Jung;
    • Jung, Sung-Hoon;
    • Kim, Kihyun;
    • Kim, Jin Seok;
    • Eom, Hyeon Seok;
    • Min, Chang Ki;
    • Moon, Joon Ho;
    • Sohn, Sang Kyun;
    • Park, Yong;
    • Lee, Ho Sup;
    • Kim, Sung-Hyun;
    • Shin, Ho-Jin;
    • Joo, Young Don;
    • Yoon, Sung-Soo;
    • Park, Seong Kyu;
    • Kwak, Jae-Young;
    • Kang, Hye Jin;
    • Choi, Yunsuk;
    • Mun, Yeung-Chul;
    • Lee, Jae Hoon
    Publication type:
    Article
    17

    The Efficacy and Safety of Lenalidomide and Dexamethasone in Patients With Relapsed/Refractory Multiple Myeloma in Real Clinical Practice : A Study of the Korean Multiple Myeloma Working Party (KMMWP).

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2017, v. 17, p. e74, doi. 10.1016/j.clml.2017.03.135
    By:
    • Lee, Ho Sup;
    • Min, Chang Ki;
    • Kim, Kihyun;
    • Lee, Je-Jung;
    • Bang, Soo-Mee;
    • Kim, Jin Seok;
    • Eom, Hyeon Seok;
    • Lee, Jae Hoon;
    • Yoon, Do Hyun;
    • Kim, Inho;
    • Shin, Ho-Jin;
    • Park, Yong;
    • Jo, Jae-Cheol;
    • Lee, Won Sik;
    • Mun, Yeung-Chul;
    • Kim, Hyo Jung;
    • Park, Seong Kyu
    Publication type:
    Article
    18

    Clinical Features and Results of Bortezomib-Melphalan-Prednisone (VMP) as Initial Treatment in Elderly Multiple Myeloma Patients Received Lenalidomide with Dexamethasone (Len/Dex): Subgroup Analysis of Lenalidomide Registry from Korean Multiple Myeloma Working Party (KMM151)

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2017, v. 17, p. e129, doi. 10.1016/j.clml.2017.03.233
    By:
    • Jo, Jae-Cheol;
    • Lee, Ho Sup;
    • Min, Chang Ki;
    • Kim, Kihyun;
    • Lee, Je-Jung;
    • Bang, Soo-Mee;
    • Kim, Jin Seok;
    • Eom, Hyeon-Seok;
    • Lee, Jae Hoon;
    • Yoon, Do Hyun;
    • Kim, Inho;
    • Shin, Ho-Jin;
    • Park, Yong;
    • Lee, Won Sik;
    • Do, Young Rok;
    • Mun, Yeung-Chul;
    • Lee, Mark Hong;
    • Kim, Hyo Jung;
    • Lim, Sung-Nam;
    • Cho, Su-Hee
    Publication type:
    Article
    19

    The outcomes of Korean Patients With Primary Plasma Cell Leukemia: Analysis of Korean Multiple Myeloma Working Party (KMM160).

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2017, v. 17, p. e38, doi. 10.1016/j.clml.2017.03.067
    By:
    • Jung, Sung-Hoon;
    • Lee, Je-Jung;
    • Kim, Kihyun;
    • Suh, Cheolwon;
    • Yoon, Do Hyun;
    • Min, Chang Ki;
    • Sohn, Sang Kyun;
    • Choi, Chul Won;
    • Lee, Ho Sup;
    • Kim, Hyo Jung;
    • Shin, Ho-Jin;
    • Bang, Soo-Mee;
    • Yoon, Sung-Soo;
    • Park, Seong Kyu;
    • Yhim, Ho-Young;
    • Kim, Min Kyoung;
    • Jo, Jae-Cheol;
    • Mun, Yeung-Chul;
    • Lee, Jae Hoon;
    • Kim, Jin Seok
    Publication type:
    Article
    20
    21
    22
    23
    24
    25
    26
    27
    28
    29
    30

    Clinical Features and Survival Outcomes in Patients with Multiple Myeloma: Analysis of Web-Based Data from the Korean Myeloma Registry.

    Published in:
    Acta Haematologica, 2009, v. 122, n. 4, p. 200, doi. 10.1159/000253027
    By:
    • Kim, Seok Jin;
    • Kim, Kihyun;
    • Kim, Byung Soo;
    • Jo, Deog-Yeon;
    • Kang, Hye Jin;
    • Kim, Jin Seok;
    • Mun, Yeung-Chul;
    • Kim, Chul Soo;
    • Sohn, Sang Kyun;
    • Eom, Hyeon-Seok;
    • Kwak, Jae-Yong;
    • Shim, Hyeok;
    • Yoon, Hwi-Joong;
    • Jin, Jong-Youl;
    • Min, Chang-Ki;
    • Shin, Hyunchoon;
    • Won, Jong-Ho;
    • Lee, Je-Jung;
    • Kwon, Jung Hye;
    • Joo, Young-Don
    Publication type:
    Article
    31
    32
    33

    A phase II study of ibrutinib in combination with rituximab-cyclophosphamide-doxorubicin hydrochloride-vincristine sulfate-prednisone therapy in Epstein-Barr virus-positive, diffuse large B cell lymphoma (54179060LYM2003: IVORY study): results of the final analysis.

    Published in:
    2020
    By:
    • Yoon, Sang Eun;
    • Kim, Seok Jin;
    • Yoon, Dok Hyun;
    • Koh, Youngil;
    • Mun, Yeung-Chul;
    • Do, Young Rok;
    • Choi, Yoon Seok;
    • Yang, Deok Hwan;
    • Kim, Min Kyoung;
    • Lee, Gyeong-Won;
    • Suh, Cheolwon;
    • Ko, Young Hyeh;
    • Kim, Won Seog
    Publication type:
    journal article
    34

    The effectiveness and safety of lenalidomide and dexamethasone in patients with relapsed/refractory multiple myeloma in real-world clinical practice: a study of the Korean Multiple Myeloma Working Party (KMMWP-151 study).

    Published in:
    2020
    By:
    • Jo, Jae-Cheol;
    • Lee, Ho Sup;
    • Kim, Kihyun;
    • Lee, Je-Jung;
    • Yoon, Sung-Soo;
    • Bang, Soo-Mee;
    • Kim, Jin Seok;
    • Eom, Hyeon-Seok;
    • Yoon, Dok Hyun;
    • Lee, Yoojin;
    • Shin, Ho-Jin;
    • Park, Yong;
    • Lee, Won Sik;
    • Do, Young Rok;
    • Mun, Yeung-Chul;
    • Lee, Mark Hong;
    • Kim, Hyo Jung;
    • Kim, Sung-Hyun;
    • Kim, Min Kyoung;
    • Lim, Sung-Nam
    Publication type:
    journal article
    35
    36
    37
    38
    39

    Chromosome 13 deletion and hypodiploidy on conventional cytogenetics are robust prognostic factors in Korean multiple myeloma patients: web-based multicenter registry study.

    Published in:
    Annals of Hematology, 2014, v. 93, n. 8, p. 1353, doi. 10.1007/s00277-014-2057-5
    By:
    • Oh, Sukjoong;
    • Koo, Dong;
    • Kwon, Min-Jung;
    • Kim, Kihyun;
    • Suh, Cheolwon;
    • Min, Chang-Ki;
    • Yoon, Sung-Soo;
    • Shin, Ho-Jin;
    • Jo, Deog-Yeon;
    • Kwak, Jae-Yong;
    • Kim, Jin;
    • Sohn, Sang;
    • Joo, Young-Don;
    • Eom, Hyeon-Seok;
    • Kim, Sung-Hyun;
    • Kim, Yang;
    • Kim, ChulSoo;
    • Mun, Yeung-Chul;
    • Kim, Hawk;
    • Lee, Dong
    Publication type:
    Article
    40

    The relationship between the success rate of empirical antifungal therapy with intravenous itraconazole and clinical parameters, including plasma levels of itraconazole, in immunocompromised patients receiving itraconazole oral solution as prophylaxis: a multicenter, prospective, open-label, observational study in Korea.

    Published in:
    2014
    By:
    • Kim, Jin Seok;
    • Cheong, June-Won;
    • Kim, Yeo-Kyeoung;
    • Park, Jinny;
    • Mun, Yeung-Chul;
    • Kang, Hye Jin;
    • Yi, Hyeon Gyu;
    • Lee, Je-Hwan;
    • Kim, Yang Soo;
    • Ryoo, Hun-Mo;
    • Kim, Sung-Hyun;
    • Kim, Ho Young;
    • Kim, Jin Young;
    • Lee, Dong-Gun;
    • Kim, Hoon-Gu;
    • Kim, Hawk;
    • Joo, Young-Don;
    • Min, Yoo Hong
    Publication type:
    Journal Article
    41

    The relationship between the success rate of empirical antifungal therapy with intravenous itraconazole and clinical parameters, including plasma levels of itraconazole, in immunocompromised patients receiving itraconazole oral solution as prophylaxis: a multicenter, prospective, open-label, observational study in Korea

    Published in:
    Annals of Hematology, 2014, v. 93, n. 1, p. 33, doi. 10.1007/s00277-013-1826-x
    By:
    • Kim, Jin;
    • Cheong, June-Won;
    • Kim, Yeo-Kyeoung;
    • Park, Jinny;
    • Mun, Yeung-Chul;
    • Kang, Hye;
    • Yi, Hyeon;
    • Lee, Je-Hwan;
    • Kim, Yang;
    • Ryoo, Hun-Mo;
    • Kim, Sung-Hyun;
    • Kim, Ho;
    • Lee, Dong-Gun;
    • Kim, Hoon-Gu;
    • Kim, Hawk;
    • Joo, Young-Don;
    • Min, Yoo
    Publication type:
    Article
    42
    43
    44

    KIT D816 mutation associates with adverse outcomes in core binding factor acute myeloid leukemia, especially in the subgroup with RUNX1/RUNX1T1 rearrangement.

    Published in:
    Annals of Hematology, 2013, v. 92, n. 2, p. 163, doi. 10.1007/s00277-012-1580-5
    By:
    • Kim, Hee-Jin;
    • Ahn, Hee;
    • Jung, Chul;
    • Moon, Joon;
    • Park, Chang-Hun;
    • Lee, Ki-O;
    • Kim, Sun-Hee;
    • Kim, Yeo-Kyeoung;
    • Kim, Hyeoung-Joon;
    • Sohn, Sang;
    • Kim, Sung;
    • Lee, Won;
    • Kim, Kyoung;
    • Mun, Yeung-Chul;
    • Kim, Hawk;
    • Park, Jinny;
    • Min, Woo-Sung;
    • Kim, Hee-Je;
    • Kim, Dong
    Publication type:
    Article
    45
    46
    47

    Comparison of various criteria in predicting treatment response and prognosis of patients with myelodysplastic syndrome treated with azacitidine.

    Published in:
    Annals of Hematology, 2010, v. 89, n. 1, p. 15, doi. 10.1007/s00277-009-0771-1
    By:
    • Dae-Young Kim;
    • Je-Hwan Lee;
    • Jung-Hee Lee;
    • Kyoo-Hyung Lee;
    • Yoe-Kyeoung Kim;
    • Jae Sook Ahn;
    • Hyeoung-Joon Kim;
    • Inho Kim;
    • Sung-Soo Yoon;
    • Seonyang Park;
    • Sung Hwa Bae;
    • Soo-Mee Bang;
    • Hong Ghi Lee;
    • Ho-Jin Shin;
    • Jae Hoon Lee;
    • Yoo Hong Min;
    • Jong-Ho Won;
    • Yeung-Chul Mun;
    • Doyeun Oh
    Publication type:
    Article
    48

    Chromosome 13 deletion and hypodiploidy on conventional cytogenetics are robust prognostic factors in Korean multiple myeloma patients: web-based multicenter registry study.

    Published in:
    2008
    By:
    • Oh, Sukjoong;
    • Koo, Dong Hoe;
    • Kwon, Min-Jung;
    • Kim, Kihyun;
    • Suh, Cheolwon;
    • Min, Chang-Ki;
    • Yoon, Sung-Soo;
    • Shin, Ho-Jin;
    • Jo, Deog-Yeon;
    • Kwak, Jae-Yong;
    • Kim, Jin Seok;
    • Sohn, Sang Kyun;
    • Joo, Young-Don;
    • Eom, Hyeon-Seok;
    • Kim, Sung-Hyun;
    • Kim, Yang Soo;
    • Kim, ChulSoo;
    • Mun, Yeung-Chul;
    • Kim, Hawk;
    • Lee, Dong Soon
    Publication type:
    Journal Article
    49
    50